← Back to Search

Multivitamin/Mineral Supplement

Redoxon VI for Vitamin D Deficiency

N/A
Waitlist Available
Led By Adrian F Gombart, PhD
Research Sponsored by Oregon State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial will test if a multivitamin/mineral supplement can help older adults' immune cells better kill bacteria.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
S. aureus clearance from whole blood
Secondary outcome measures
Determine phagocytic activity of neutrophils by measuring uptake of fluorescently labeled Escherichia coli using flow cytometry
Number of neutrophils, monocytes and lymphocytes
Serum levels of inflammatory cytokines
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Redoxon VIExperimental Treatment1 Intervention
2 film coated tablets Redoxon VI oral intake daily for 12 weeks
Group II: PlaceboPlacebo Group1 Intervention
2 film coated tablets placebo oral intake daily for 12 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Redoxon VI
2016
N/A
~50

Find a Location

Who is running the clinical trial?

Oregon State UniversityLead Sponsor
49 Previous Clinical Trials
8,339 Total Patients Enrolled
Adrian F Gombart, PhDPrincipal InvestigatorPrincipal Investigator

Frequently Asked Questions

~5 spots leftby Apr 2025